WELSPUN LIVING: Q4 REVENUE 24.35B RUPEES VS 26.5B (YOY)

WELSPUN LIVING: Q4 CONS NET PROFIT 1B RUPEES VS 1.32B (YOY)

WELSPUN LIVING: CO APPROVED BUYBACK SHARES AT PRICE OF RS 175 PER SHARE VIA TENDER OFFER

ZUARI AGRO CHEMICALS: Q4 CONS NET LOSS 250M RUPEES VS PROFIT 198.4M (YOY) || Q4 REVENUE 2B RUPEES VS 9.52B (YOY)

NAVA: Q4 EBITDA 3.71B RUPEES VS 3.8B (YOY) || Q4 EBITDA MARGIN 32.48% VS 37.48% (YOY)

NAVA: Q4 REVENUE 11.4B RUPEES VS 10.2B (YOY)

NAVA: Q4 CONS NET PROFIT 1.3B RUPEES VS 2.34B (YOY)

TV TODAY NETWORK: Q4 EBITDA 46M RUPEES VS 46M (YOY) || Q4 EBITDA MARGIN 2.14% VS 1.83% (YOY)

TV TODAY NETWORK: Q4 REVENUE 2.13B RUPEES VS 2.5B (YOY)

TV TODAY NETWORK: Q4 CONS NET PROFIT 90M RUPEES VS 62M (YOY)

Ola Electric Mobility: Approves ₹2,000 Crore Investment in Subsidiaries Ola Electric Technologies and Ola Cell Technologies, Set to Complete by May 14, 2027.

MODI'S NAVNIRMAN: Q4 EBITDA 76M RUPEES VS 39M (YOY) || Q4 EBITDA MARGIN 14.76% VS 19.66% (YOY)

MODI'S NAVNIRMAN: Q4 SL NET PROFIT 44M RUPEES VS 15M (YOY) || Q4 REVENUE 515M RUPEES VS 199M (YOY)

RANE HOLDINGS: Q4 EBITDA 1.26B RUPEES VS 953M (YOY) || Q4 EBITDA MARGIN 7.84% VS 6.94% (YOY)

RANE HOLDINGS: Q4 REVENUE 16B RUPEES VS 14B (YOY)

RANE HOLDINGS: Q4 CONS NET PROFIT 740M RUPEES VS 94M (YOY)

Senores Pharma: Co Have A 30-40% Revenue Growth Est For Fy27 & Around 60% Profit Growth In Fy27